심혈관 건강보조제 시장 규모, 점유율, 동향 분석 보고서 : 유형별, 형상별, 성분별, 유통 채널별, 지역별, 부문 예측(2025-2030년)

Cardiovascular Health Supplements Market Growth & Trends:

The global cardiovascular health supplements market size is expected to reach USD 16.72 billion by 2030, registering a CAGR of 8.6% from 2025 to 2030, according to a new report by Grand View Research, Inc. Factors such as rising awareness about healthcare, a growing population suffering from cholesterol, obesity, cardiovascular disease, and poor dietary habits are driving the demand for cardiovascular supplements over the forecast period. According to World Heart Federation, every year globally approximately 4.4 million people die due to high cholesterol. Supplements like plant sterols or stanols can help lower LDL (bad) cholesterol levels by interfering with cholesterol absorption in the intestines. This can contribute to a lower risk of atherosclerosis (hardening of the arteries).

Consumers are becoming more interested in healthy diets and lifestyle modifications as they become more aware of high-quality foods that contribute to excellent well-being and include nutritional value. Obesity is becoming a growing concern for today's consumers, owing mostly to sedentary lifestyles and poor eating habits. As a result, there is an increased need for supplements that provide significant health benefits, thereby contributing to the prevention of heart disease. Cardiovascular health supplements, in this way, meet consumer demand by delivering heart health support as well as other critical nutrients for general health.

One notable trend in the market is the increasing preference for natural and plant-based ingredients. Consumers are looking for products that are free from artificial additives and chemicals, such as supplements containing plant sterols and phytosterols. Omega-3 fatty acids, found in fish oil supplements, continue to be a popular choice for heart-related problems. Research has consistently shown their benefits in reducing the risk of heart disease. Moreover, personalized supplements are gaining traction, with companies offering tailored solutions based on individual health profiles and genetic factors. This trend allows consumers to address specific cardiovascular health needs more effectively.

Growing startups, investments, and funding by market players to expand their nutritional platforms are expected to drive market growth over the coming years. For instance, in December 2022, HealthKart raised a total of USD 135 million in funding led by Temasek. The funding helps the company to expand its online and offline presence worldwide.

Cardiovascular Health Supplements Market Report Highlights:

• The natural supplements segment held the largest market share of 69.7% in 2024 and is expected to grow at the fastest CAGR of 9.0% over the forecast period.
• The omega fatty acids segment held the largest revenue share of 27.0% in 2024. Scientific research has consistently demonstrated the significant cardiovascular benefits of omega-3 fatty acids, particularly Eicosapentaenoic Acid (EPA) and Docosahexaenoic Acid (DHA).
• The softgels segment held the largest share of 36.6% in 2024. Softgels are known for their ease of consumption and digestibility, making them a preferred choice for individuals seeking cardiovascular health support.
• The offline segment held the largest market share of 70.7% in 2024. It includes brick-and-mortar stores, pharmacies, and health food stores, which offer consumers a physical location to explore and purchase health supplements.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Market Definitions
• 1.3. Research Methodology
  • 1.3.1. Information Procurement
  • 1.3.2. Information or Data Analysis
  • 1.3.3. Market Formulation & Data Visualization
  • 1.3.4. Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. Cardiovascular Health Supplements Market Variables, Trends, & Scope

• 3.1. Market Introduction/Lineage Outlook
• 3.2. Market Size and Growth Prospects (USD Million)
• 3.3. Market Dynamics
  • 3.3.1. Market Drivers Analysis
  • 3.3.2. Market Restraints Analysis
• 3.4. Cardiovascular Health Supplements Market Analysis Tools
  • 3.4.1. Porter's Analysis
    • 3.4.1.1. Bargaining power of the suppliers
    • 3.4.1.2. Bargaining power of the buyers
    • 3.4.1.3. Threats of substitution
    • 3.4.1.4. Threats from new entrants
    • 3.4.1.5. Competitive rivalry
  • 3.4.2. PESTEL Analysis
    • 3.4.2.1. Political landscape
    • 3.4.2.2. Economic and Social landscape
    • 3.4.2.3. Technological landscape
    • 3.4.2.4. Environmental landscape
    • 3.4.2.5. Legal landscape

Chapter 4. Cardiovascular Health Supplements Market: Type Estimates & Trend Analysis

• 4.1. Type Market Share, 2024 & 2030
• 4.2. Type Segment Dashboard
• 4.3. Market Size & Forecasts and Trend Analysis, by Type, 2018 to 2030 (USD Million)
• 4.4. Natural Supplements
  • 4.4.1. Natural supplements Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.5. Synthetic Supplements
  • 4.5.1. Synthetic Supplements Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Cardiovascular Health Supplements Market: Ingredient Estimates & Trend Analysis

• 5.1. Ingredient Market Share, 2024 & 2030
• 5.2. Ingredient Segment Dashboard
• 5.3. Market Size & Forecasts and Trend Analysis, by Ingredient Class, 2018 to 2030 (USD Million)
• 5.4. Vitamins & Minerals
  • 5.4.1. Vitamins & Minerals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.5. Herbs & Botanicals
  • 5.5.1. Herbs & Botanicals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.6. Omega Fatty Acids
  • 5.6.1. Omega Fatty Acids Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.7. Coenzyme Q10 (CoQ10)
  • 5.7.1. Coenzyme Q10 (CoQ10) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.8. Others
  • 5.8.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Cardiovascular Health Supplements Market: Form Estimates & Trend Analysis

• 6.1. Form Market Share, 2024 & 2030
• 6.2. Form Segment Dashboard
• 6.3. Market Size & Forecasts and Trend Analysis, by Form, 2018 to 2030 (USD Million)
• 6.4. Liquid
  • 6.4.1. Liquid Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.5. Tablet
  • 6.5.1. Tablet Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.6. Capsules
  • 6.6.1. Capsules Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.7. Softgels
  • 6.7.1. Softgels Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.8. Powder
  • 6.8.1. Powder Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.9. Others
  • 6.9.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Cardiovascular Health Supplements Market: Distribution Channel Estimates & Trend Analysis

• 7.1. Distribution Channel Market Share, 2024 & 2030
• 7.2. Distribution Channel Segment Dashboard
• 7.3. Market Size & Forecasts and Trend Analysis, by Distribution Channel, 2018 to 2030 (USD Million)
• 7.4. Offline
  • 7.4.1. Offline Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.5. Online
  • 7.5.1. Online Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Cardiovascular Health Supplements Market: Regional Estimates & Trend Analysis

• 8.1. Regional Market Share Analysis, 2024 & 2030
• 8.2. Regional Market Dashboard
• 8.3. Market Size & Forecasts Trend Analysis, 2018 to 2030
• 8.4. North America
  • 8.4.1. North America Cardiovascular Health Supplements Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.4.2. U.S.
    • 8.4.2.1. Key Country Dynamics
    • 8.4.2.2. Regulatory Framework
    • 8.4.2.3. Competitive Insights
    • 8.4.2.4. U.S. Cardiovascular Health Supplements Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.4.3. Canada
    • 8.4.3.1. Key Country Dynamics
    • 8.4.3.2. Regulatory Framework
    • 8.4.3.3. Competitive Insights
    • 8.4.3.4. Canada Cardiovascular Health Supplements Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.4.4. Mexico
    • 8.4.4.1. Key Country Dynamics
    • 8.4.4.2. Regulatory Framework
    • 8.4.4.3. Competitive Insights
    • 8.4.4.4. Mexico Cardiovascular Health Supplements Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 8.5. Europe
  • 8.5.1. Europe Cardiovascular Health Supplements Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5.2. Germany
    • 8.5.2.1. Key Country Dynamics
    • 8.5.2.2. Regulatory Framework
    • 8.5.2.3. Competitive Insights
    • 8.5.2.4. Germany Cardiovascular Health Supplements Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5.3. UK
    • 8.5.3.1. Key Country Dynamics
    • 8.5.3.2. Regulatory Framework
    • 8.5.3.3. Competitive Insights
    • 8.5.3.4. UK Cardiovascular Health Supplements Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5.4. France
    • 8.5.4.1. Key Country Dynamics
    • 8.5.4.2. Regulatory Framework
    • 8.5.4.3. Competitive Insights
    • 8.5.4.4. France Cardiovascular Health Supplements Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5.5. Italy
    • 8.5.5.1. Key Country Dynamics
    • 8.5.5.2. Regulatory Framework
    • 8.5.5.3. Competitive Insights
    • 8.5.5.4. Italy Cardiovascular Health Supplements Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5.6. Spain
    • 8.5.6.1. Key Country Dynamics
    • 8.5.6.2. Regulatory Framework
    • 8.5.6.3. Competitive Insights
    • 8.5.6.4. Spain Cardiovascular Health Supplements Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5.7. Sweden
    • 8.5.7.1. Key Country Dynamics
    • 8.5.7.2. Regulatory Framework
    • 8.5.7.3. Competitive Insights
    • 8.5.7.4. Sweden Cardiovascular Health Supplements Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5.8. Denmark
    • 8.5.8.1. Key Country Dynamics
    • 8.5.8.2. Regulatory Framework
    • 8.5.8.3. Competitive Insights
    • 8.5.8.4. Denmark Cardiovascular Health Supplements Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5.9. Norway
    • 8.5.9.1. Key Country Dynamics
    • 8.5.9.2. Regulatory Framework
    • 8.5.9.3. Competitive Insights
    • 8.5.9.4. Norway Cardiovascular Health Supplements Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 8.6. Asia Pacific
  • 8.6.1. Asia Pacific Cardiovascular Health Supplements Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.6.2. China
    • 8.6.2.1. Key Country Dynamics
    • 8.6.2.2. Regulatory Framework
    • 8.6.2.3. Competitive Insights
    • 8.6.2.4. China Cardiovascular Health Supplements Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.6.3. Japan
    • 8.6.3.1. Key Country Dynamics
    • 8.6.3.2. Regulatory Framework
    • 8.6.3.3. Competitive Insights
    • 8.6.3.4. Japan Cardiovascular Health Supplements Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.6.4. India
    • 8.6.4.1. Key Country Dynamics
    • 8.6.4.2. Regulatory Framework
    • 8.6.4.3. Competitive Insights
    • 8.6.4.4. India Cardiovascular Health Supplements Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.6.5. South Korea
    • 8.6.5.1. Key Country Dynamics
    • 8.6.5.2. Regulatory Framework
    • 8.6.5.3. Competitive Insights
    • 8.6.5.4. South Korea Cardiovascular Health Supplements Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.6.6. Australia
    • 8.6.6.1. Key Country Dynamics
    • 8.6.6.2. Regulatory Framework
    • 8.6.6.3. Competitive Insights
    • 8.6.6.4. Australia Cardiovascular Health Supplements Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.6.7. Thailand
    • 8.6.7.1. Key Country Dynamics
    • 8.6.7.2. Regulatory Framework
    • 8.6.7.3. Competitive Insights
    • 8.6.7.4. Thailand Cardiovascular Health Supplements Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 8.7. Latin America
  • 8.7.1. Latin America Cardiovascular Health Supplements Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.7.2. Brazil
    • 8.7.2.1. Key Country Dynamics
    • 8.7.2.2. Regulatory Framework
    • 8.7.2.3. Competitive Insights
    • 8.7.2.4. Brazil Cardiovascular Health Supplements Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.7.3. Argentina
    • 8.7.3.1. Key Country Dynamics
    • 8.7.3.2. Regulatory Framework
    • 8.7.3.3. Competitive Insights
    • 8.7.3.4. Argentina Cardiovascular Health Supplements Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 8.8. Middle East and Africa
  • 8.8.1. Middle East and Africa Cardiovascular Health Supplements Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.8.2. South Africa
    • 8.8.2.1. Key Country Dynamics
    • 8.8.2.2. Regulatory Framework
    • 8.8.2.3. Competitive Insights
    • 8.8.2.4. South Africa Cardiovascular Health Supplements Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.8.3. Saudi Arabia
    • 8.8.3.1. Key Country Dynamics
    • 8.8.3.2. Regulatory Framework
    • 8.8.3.3. Competitive Insights
    • 8.8.3.4. Saudi Arabia Cardiovascular Health Supplements Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.8.4. UAE
    • 8.8.4.1. Key Country Dynamics
    • 8.8.4.2. Regulatory Framework
    • 8.8.4.3. Competitive Insights
    • 8.8.4.4. UAE Cardiovascular Health Supplements Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.8.5. Kuwait
    • 8.8.5.1. Key Country Dynamics
    • 8.8.5.2. Regulatory Framework
    • 8.8.5.3. Competitive Insights
    • 8.8.5.4. Kuwait Cardiovascular Health Supplements Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 9. Competitive Landscape

• 9.1. Participant Overview
• 9.2. Company Market Position Analysis
• 9.3. Company Categorization
• 9.4. Strategy Mapping
• 9.5. Company Profiles/Listing
  • 9.5.1. NOW Foods
    • 9.5.1.1. Participant's Overview
    • 9.5.1.2. Financial Performance
    • 9.5.1.3. Product Benchmarking
    • 9.5.1.4. Recent Developments/ Strategic Initiatives
  • 9.5.2. Bright Lifecare Private Ltd (Truebasics.com)
    • 9.5.2.1. Participant's Overview
    • 9.5.2.2. Financial Performance
    • 9.5.2.3. Product Benchmarking
    • 9.5.2.4. Recent Developments/ Strategic Initiatives
  • 9.5.3. Natural Organics, Inc.
    • 9.5.3.1. Participant's Overview
    • 9.5.3.2. Financial Performance
    • 9.5.3.3. Product Benchmarking
    • 9.5.3.4. Recent Developments/ Strategic Initiatives
  • 9.5.4. DaVinci Laboratories of Vermont
    • 9.5.4.1. Participant's Overview
    • 9.5.4.2. Financial Performance
    • 9.5.4.3. Product Benchmarking
    • 9.5.4.4. Recent Developments/ Strategic Initiatives
  • 9.5.5. Nordic Naturals
    • 9.5.5.1. Participant's Overview
    • 9.5.5.2. Financial Performance
    • 9.5.5.3. Product Benchmarking
    • 9.5.5.4. Recent Developments/ Strategic Initiatives
  • 9.5.6. Thorne
    • 9.5.6.1. Participant's Overview
    • 9.5.6.2. Financial Performance
    • 9.5.6.3. Product Benchmarking
    • 9.5.6.4. Recent Developments/ Strategic Initiatives
  • 9.5.7. Nestle Health Science (Pure Encapsulations, LLC.)
    • 9.5.7.1. Participant's Overview
    • 9.5.7.2. Financial Performance
    • 9.5.7.3. Product Benchmarking
    • 9.5.7.4. Recent Developments/ Strategic Initiatives
  • 9.5.8. Amway Corp.
    • 9.5.8.1. Participant's Overview
    • 9.5.8.2. Financial Performance
    • 9.5.8.3. Product Benchmarking
    • 9.5.8.4. Recent Developments/ Strategic Initiatives
  • 9.5.9. InVite Health
    • 9.5.9.1. Participant's Overview
    • 9.5.9.2. Financial Performance
    • 9.5.9.3. Product Benchmarking
    • 9.5.9.4. Recent Developments/ Strategic Initiatives
  • 9.5.10. GNC Holdings, LLC
    • 9.5.10.1. Participant's Overview
    • 9.5.10.2. Financial Performance
    • 9.5.10.3. Product Benchmarking
    • 9.5.10.4. Recent Developments/ Strategic Initiatives